Diphtheria, Tetanus, Acellular Pertussis, Poliovirus & Haemophilus influenzae type b Vaccine (DTaP-IPV-Hib)
No
Yes
Dear Healthcare Professional Letters
Subsidised Vaccine List
Active ingredients: Vaccine Diphtheria | Diphtheria Vaccine | Vaccine Tetanus | Tetanus Vaccine | Vaccine Pertussis | Pertussis Vaccine | Vaccine Poliovirus | Poliovirus Vaccine | Vaccine Haemophilus Influenzae Type B | Haemophilus Influenzae Type B Vaccine | Diphtheria, Tetanus, Acellular Pertussis, Poliovirus & Haemophilus influenzae type b Vaccine (DTaP-IPV-Hib)
General information
Subsidy Information and Financing Scheme
[SVL] Diphtheria, Tetanus, Acellular Pertussis, Poliovirus & Haemophilus influenzae type b Vaccine (DTaP-IPV-Hib) (Infanrix-IPV+Hib) Injection, Diphtheria Toxoid Vaccine minimum 30 international units/0.5 mL + Tetanus Toxoid Vaccine minimum 40 international units/0.5 mL + Pertussis Toxoid Vaccine 25 micrograms/0.5 mL + Filamentous Haemagglutinin 25 micrograms/0.5 mL + Pertactin 8 micrograms/0.5 mL + Poliovirus Vaccine (inactivated) Type-1 40 D-antigen unit/0.5 mL + Poliovirus Vaccine (inactivated) Type-2 8 D-antigen unit/0.5 mL + Poliovirus Vaccine (inactivated) Type-3 32 D-antigen unit/0.5 mL + Haemophilus influenzae type B Vaccine 10 micrograms/0.5 mL
National Childhood Immunisation Schedule (NCIS)
[SVL] Diphtheria, Tetanus, Acellular Pertussis, Poliovirus & Haemophilus influenzae type b Vaccine (DTaP-IPV-Hib) (Pentaxim) Injection, Diphtheria Toxoid Vaccine minimum 30 international units/0.5 mL + Tetanus Toxoid Vaccine minimum 40 international units/0.5 mL + Pertussis Toxoid Vaccine 25 micrograms/0.5 mL + Filamentous Haemagglutinin 25 micrograms/0.5 mL + Poliovirus Vaccine (inactivated) Type-1 40 D-antigen unit/0.5 mL + Poliovirus Vaccine (inactivated) Type-2 8 D-antigen unit/0.5 mL + Poliovirus Vaccine (inactivated) Type-3 32 D-antigen unit/0.5 mL + Haemophilus influenzae type B Vaccine 10 micrograms/0.5 mL
National Childhood Immunisation Schedule (NCIS)
Drug Guidance for Subsidy
Not Applicable
Post Marketing Information
General Availability in Public Healthcare Institution
Note:
General availability information reflected is based on the Public Healthcare Institutions’ (PHI) formulary on what is commonly used for treating their patient population and may or may not be available for patients not under the care of that institution. It does not reflect the PHI’s actual inventory availability and is subjected to change. Please consult the Public Hospitals or Polyclinics for details on availability and supply restrictions/considerations. General availability is not tied to any brand unless otherwise stated.
Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration
Availability information
Formulation | Public Healthcare Institution |
|---|---|
Infanrix-IPV+Hib Injection, Diphtheria Toxoid Vaccine minimum 30 international units/0.5 mL + Tetanus Toxoid Vaccine minimum 40 international units/0.5 mL + Pertussis Toxoid Vaccine 25 micrograms/0.5 mL + Filamentous Haemagglutinin 25 micrograms/0.5 mL + Pertactin 8 micrograms/0.5 mL + Poliovirus Vaccine (inactivated) Type-1 40 D-antigen unit/0.5 mL + Poliovirus Vaccine (inactivated) Type-2 8 D-antigen unit/0.5 mL + Poliovirus Vaccine (inactivated) Type-3 32 D-antigen unit/0.5 mL + Haemophilus influenzae type B Vaccine 10 micrograms/0.5 mL |
|
Pentaxim Injection, Diphtheria Toxoid Vaccine minimum 30 international units/0.5 mL + Tetanus Toxoid Vaccine minimum 40 international units/0.5 mL + Pertussis Toxoid Vaccine 25 micrograms/0.5 mL + Filamentous Haemagglutinin 25 micrograms/0.5 mL + Poliovirus Vaccine (inactivated) Type-1 40 D-antigen unit/0.5 mL + Poliovirus Vaccine (inactivated) Type-2 8 D-antigen unit/0.5 mL + Poliovirus Vaccine (inactivated) Type-3 32 D-antigen unit/0.5 mL + Haemophilus influenzae type B Vaccine 10 micrograms/0.5 mL |
|
